Back to all studies
RecruitingISRCTN57292778

Cost-effectiveness of cognitive behaviour therapy of cognitive behaviour therapy for recent onset schizophrenia patients with persistent and recurrent psychosis.

This recruiting study focuses on schizophrenia and currently lists sites or participation links in Netherlands.

SchizophreniaOtherFrom 18 Years to 64 Years
In plain English

Key information made simple

This study is looking at whether Please note that, as of 30/07/2008, the end date of this trial has been updated from 01/12/2007 to 01/04/2008 can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Please note that, as of 30/07/2008, the end date of this trial has been updated from 01/12/2007 to 01/04/2008 and complete follow-up assessments. Taking part may give some people access to Please note that, as of 30/07/2008, the end date of this trial has been updated from 01/12/2007 to 01/04/2008, but direct benefit is not guaranteed.

What to expect

Your next step

The official record does not clearly describe the visit format, so the practical details are best checked directly in the source. Participation appears to involve study activities and follow-up chosen by the research team. The main fit and exclusions are best confirmed in the eligibility section of the official record. The phase details are not clearly stated here.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Need help deciding?

Ask HopeStage to review this study with me

This form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.

Loading the security check...
Study reference: ISRCTN57292778. We only ask for your email here. HopeStage can help you review the study, but this is not a medical eligibility decision.
In practice

For you

Taking part may help improve understanding of your condition.

It requires regular follow-up, often through questionnaires or interviews.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com